Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 3 5Phase NA 3Phase EARLY_PHASE1 2Phase 1/2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Breast Cancer Female 1

Interventions

Letrozole 7Fluorodeoxyglucose F18 7Magnetic Resonance Spectroscopy 5Blood Specimen Collection 5pembrolizumab 4atezolizumab 4Trastuzumab 4Oncolytic Virotherapy 4Bevacizumab 4palbociclib 3Saline Solution 3Fish Oils 3Docosahexaenoic Acids 3Denosumab 3Carboplatin 3Biopsy 3pertuzumab 2olaparib 2Vitamin D 2Vinorelbine 2Taxes 2Sentinel Lymph Node Biopsy 2Radiotherapy 2Positron-Emission Tomography 2Positron Emission Tomography Computed Tomography 2Paclitaxel 2Omacor 2Neoadjuvant Therapy 2Metformin 2Lapatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Breast Neoplasms × Vitamin D × Clear all
NCT03629717 2024-10-16

RANKL Inhibition and Breast Tissue Biomarkers

Washington University School of Medicine

Phase EARLY_PHASE1 Completed
10 enrolled
Breast

Breast Neoplasms

NCT00263185 2014-09-22

High Dose Vit D Musculoskeletal Symptoms & Bone Density in Anastrozole-Treated Breast Cancer With Marginal Vit D Status

Washington University School of Medicine

Phase EARLY_PHASE1 Completed
63 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡